Definition
Von Hippel-Lindau disease is a multisystem tumor syndrome first described by Eugen Von Hippel in 1904 (ophthalmic angiomas) and subsequently by Arvid Lindau in 1927 (cerebellar and spinal angiomas). It is classically characterized by a number of both endocrine and non-endocrine lesions including hemangioblastomas of the central nervous system and retina, clear cell renal cell carcinoma, endolymphatic sac tumor, pheochromocytomas, extra-adrenal paragangliomas, neuroendocrine tumors and cystadenomas of the pancreas, papillary cystadenomas of the broad ligament and epididymis, and ovarian steroid cell tumors. Depending on the genotypic alteration in VHL,four genotype-phenotype variants exist including Type 1 (due to deletions), as well as Types 2A, 2B, and 2C...
References and Further Reading
Barontini, M., & Dahia, P. L. (2010). VHL disease. Best Practice and Research: Clinical Endocrinology and Metabolism, 24, 401–413.
Cassol, C., & Mete, O. (2015). Endocrine manifestations of von Hippel-Lindau disease. Archives of Pathology and Laboratory Medicine., 139, 263–268.
Duan, K., & Mete, O. (2017). Hereditary endocrine tumor syndromes: The clinical and predictive role of molecular histopathology. AJSP: Reviews & Reports, 22, 246–268.
Favier, J., Méatchi, T., Robidel, E., Badoual, C., Sibony, M., Nguyen, A. T., Gimenez-Roqueplo, A., & Burnichon, N. (2019). Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma—A retrospective and prospective study. Modern Pathology, 1–8.
Gucer, H., Szentgyorgyi, E., Ezzat, S., Asa, S. L., Mete, O. (2013). Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease. Virchows Arch, 463, 593–597.
Koch, C. A., Mauro, D., Walther, M. M., Linehan, W. M., Vortmeyer, A. O., Jaffe, R., Pacak, K., Chrousos, G. P., Zhuang, Z., & Lubensky, I. A. (2002). Pheochromocytoma in von HippelLindau disease: Distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocrine Pathology, 13, 17–27.
Lubensky, I. A., Pack, S., Ault, D., Vortmeyer, A. O., Libutti, S. K., Choyke, P. L., Walther, M. M., Linehan, W. M., & Zhugang, Z. (1998). Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: Histopathological and molecular genetic analysis. The American Journal of Pathology, 153, 223–231.
Maher, E. (2004). Von Hippel-Lindau disease. Current Molecular Medicine, 4, 833–842.
Maher, E. R., Iselius, L., Yates, J. R., Littler, M., Benjamin, C., Harris, R., Sampson, J., Williams, A., Ferguson-Smith, M. A., & Morton, N. (1991). Von Hippel-Lindau disease: A genetic study. Journal of Medical Genetics, 28, 443–447.
Marques, A., & Portugal, R. (2019). Ovarian steroid cell tumor in an adolescent with Von Hippel-Lindau syndrome: A case report and review of the literature. International Journal of Gynecologic Pathology. https://doi.org/10.1097/PGP.0000000000000628. [Epub ahead of print].
Mete, O., & Asa, S. L. (2013). Precursor lesions of endocrine system neoplasms. Pathology, 45, 316–330.
Molino, D., Sepe, J., Anastasio, P., & De Santo, N. G. The history of von Hippel-Lindau disease (2006). Journal of Nephrology, 19(Suppl 10), S119–S123.
Safo, A. O., & Pambuccian, S. E. (2010). Pancreatic manifestations of von Hippel-Lindau disease. Archives of Pathology and Laboratory Medicine, 134, 1080–1083.
Schaller, T., Bode, M., Berlisa, A., Fruhwald, M. C., Lichtmannegger, I., Endhardt, K., & Markl, B. (2015). Specific immunohistochemical pattern of carbonic anhydrase IX is helpful for the diagnosis of CNS hemangioblastoma. Pathology Research and Practice, 211, 513–520.
Shuin, T., Yamasaki, I., Tamura, K., Okuda, H., Furihata, M., & Ashida, S. (2006). Von Hippel-Lindau disease: Molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Japanese Journal of Clinical Oncology, 36, 337–343.
Sinkre, P. A., Murakata, L., Rabin, L., Hoang, M. P., Albores-Saavedra, J. (2001). Clear cell carcinoid tumor of the gallbladder: another distinctive manifestation of von Hippel-Lindau disease. Am J Surg Pathol. 25, 1334–1339.
Srirangalingam, U., Khoo, B., Walker, L., MacDonald, F., Skelly, R. H., Geroge, E., Spooner, D., Johnston, L. B., Monson, P., Grossman, A. B., Drake, W. M., Akker, S. A., Pollard, P. J., Lowman, N., Avril, N., Berney, D. M., Burrin, J. M., Reznek, R. H., Kumar, V. K., Maher, E. R., & Chew, S. L. (2009). Contrasting clinical manifestations of SDHB and VHL association chromaffin tumours. Endocrine Related Cancer, 16, 515–525.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Hodgson, A., Pakbaz, S., Mete, O. (2020). Von Hippel-Lindau Disease. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5229-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_5229-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine